Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,275 | 78,964 | 83,523 | 139,526 | 112,219 |
| Marketable Securities | N/A | N/A | 24,781 | N/A | 0 |
| Receivables | N/A | N/A | N/A | N/A | 1,665 |
| TOTAL | $63,931 | $84,921 | $112,202 | $144,980 | $122,515 |
| Non-Current Assets | |||||
| PPE Net | 6,308 | 6,633 | 6,964 | 7,298 | 7,614 |
| Other Non-Current Assets | 14,756 | 15,168 | 15,562 | 15,896 | 17,666 |
| TOTAL | $21,064 | $21,801 | $22,526 | $23,194 | $25,280 |
| Total Assets | $84,995 | $106,722 | $134,728 | $168,174 | $147,795 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 11,667 | 6,667 | 1,667 |
| Accounts payable and accrued liabilities | 9,646 | 7,469 | 11,346 | 11,544 | 2,855 |
| Accrued Expenses | 16,162 | 14,557 | 11,881 | 16,146 | 21,489 |
| TOTAL | $28,392 | $24,521 | $37,303 | $36,681 | $28,394 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41,081 | 40,934 | 29,708 | 34,556 | 39,406 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 139 |
| Other Non-Current Liabilities | 26,645 | 47,619 | 52,660 | 80,275 | 43,693 |
| TOTAL | $67,726 | $88,553 | $82,368 | $114,831 | $83,099 |
| Total Liabilities | $96,118 | $113,074 | $119,671 | $151,512 | $111,493 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,832 | 26,810 | 26,728 | 26,454 | 21,067 |
| Common Shares | 27 | 26 | 26 | 26 | 21 |
| Retained earnings | -756,238 | -749,842 | -726,515 | -722,807 | -658,423 |
| TOTAL | $-11,123 | $-6,352 | $15,057 | $16,662 | $36,302 |
| Total Liabilities And Equity | $84,995 | $106,722 | $134,728 | $168,174 | $147,795 |